Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$4.7M
+7.1% from 2023
Prescriptions
919
$5,106.56 per claim
Patients
122
93 prescribers
Total spending, 2024
$4.7M
$38,466.60 per patient
Medicare prescription drug plans paid $4.7M for Herceptin in 2024, for 919 prescriptions and refills to 122 patients (up 7.1% from 2023). The average cost per claim was $5,106.56.
California had the highest Medicare cost for Herceptin in 2024: $1.1M for 233 claims, followed by Texas ($830K).
Rahul R Naik, hematology-oncology in Los Angeles, CA, had the highest Medicare cost for Herceptin in 2024: 62 claims costing $314K.
Herceptin is made by Roche Holding AG (ROG.SW), listed in the Medicare spending data as Genentech, Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Rahul R Naik Los Angeles, CA | Hematology-Oncology | 62 | Under 11 | $314K |
| Antoine E Chahine Canfield, OH | Medical Oncology | 59 | Under 11 | $230K |
| Swetha S Yadav |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 120 | 1,044 | 162 | $6.0M |
| 2023 | 79 | 838 | 105 | $4.4M |
| 2024 | 93 | 919 | 122 | $4.7M |
Spending by manufacturer as listed in the spending data
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 45 |
| Under 11 |
| $225K |
| Maria A Scouros Houston, TX | Hematology-Oncology | 49 | Under 11 | $216K |
| Javier Ruiz New Windsor, NY | Hematology-Oncology | 30 | Under 11 | $188K |
| Arjun Iyengar New York, NY | Hematology-Oncology | 31 | Under 11 | $126K |
| Youram Nassir Los Angeles, CA | Hematology | 20 | Under 11 | $118K |
| Trina Poretta Voorhees, NJ | Hematology-Oncology | 17 | Under 11 | $103K |
| Gargi H Upadhyaya Pasadena, CA | Hematology-Oncology | 23 | Under 11 | $99K |
| Mihran Shirinian Glendale, CA | Hematology-Oncology | 22 | Under 11 | $97K |
| Zili He X Flushing, NY | Hematology-Oncology | 27 | Under 11 | $93K |
| Amer Rafiaa Brooklyn, NY | Hematology-Oncology | 16 | Under 11 | $93K |
| Luis O Negron-Garcia San German, PR | Hematology-Oncology | 15 | Under 11 | $92K |
| Ann M Wierman Las Vegas, NV | Hematology-Oncology | 12 | Under 11 | $89K |
| Amanda Gilley Victoria, TX | Nurse Practitioner | 14 | Under 11 | $87K |
| Francis P Matuszak Ocala, FL | Medical Oncology | 14 | Under 11 | $86K |
| Caroline M Behler San Francisco, CA | Hematology-Oncology | 18 | Under 11 | $85K |
| Shahab A Khan Houston, TX | Hematology-Oncology | 14 | Under 11 | $82K |
| Kirtan N Koticha Shreveport, LA | Hematology-Oncology | 17 | Under 11 | $75K |
| David A Richards Somerset, NJ | Hematology-Oncology | 17 | Under 11 | $75K |
| Nanda Biswas Victorville, CA | Internal Medicine | 13 | Under 11 | $74K |
| Shailja Roy Vineland, NJ | Hematology-Oncology | 16 | Under 11 | $73K |
| Eddiemar Ortiz Cruz San Juan, PR | Hematology-Oncology | 15 | Under 11 | $70K |
| Samuel D Bailey Hazard, KY | Hematology-Oncology | 17 | Under 11 | $68K |
| Mustafa G Boxwala Farmington Hills, MI | Medical Oncology | 11 | Under 11 | $64K |
| Manufacturer | Claims | Spending |
|---|---|---|
| Genentech, Inc. ROG.SW | 919 | $4.7M |